Stay updated with breaking news from Compugen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Compugen Ltd. (NASDAQ:CGEN – Get Rating) – Stock analysts at Oppenheimer lowered their Q2 2022 earnings per share (EPS) estimates for shares of Compugen in a research note issued to investors on Monday, May 16th. Oppenheimer analyst M. Breidenbach now forecasts that the biotechnology company will post earnings per share of ($0.12) for the quarter, […]
Compugen Ltd. (NASDAQ:CGEN – Get Rating) – Equities research analysts at SVB Leerink increased their Q2 2022 earnings per share (EPS) estimates for shares of Compugen in a research note issued on Tuesday, May 17th. SVB Leerink analyst D. Graybosch now anticipates that the biotechnology company will post earnings per share of ($0.11) for the […]
StockNews.com lowered shares of Compugen (NASDAQ:CGEN – Get Rating) from a hold rating to a sell rating in a research report sent to investors on Thursday morning. A number of other equities research analysts have also recently commented on CGEN. Zacks Investment Research cut shares of Compugen from a buy rating to a hold rating […]
Compugen (NASDAQ:CGEN – Get Rating) is set to announce its earnings results before the market opens on Monday, May 16th. Analysts expect the company to announce earnings of ($0.12) per share for the quarter. Compugen (NASDAQ:CGEN – Get Rating) last posted its quarterly earnings results on Thursday, February 24th. The biotechnology company reported ($0.10) EPS […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.